IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis-Reference-Cited by-同舟云学术

IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis

Published:2016-01-12 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Asano Yoshinori,Kawase Tatsuya,Okabe Atsushi,Tsutsumi Shuichi,Ichikawa Hitoshi,Tatebe Satoko,Kitabayashi Issay,Tashiro Fumio,Namiki Hideo,Kondo Tadashi,Semba Kentaro,Aburatani Hiroyuki,Taya Yoichi,Nakagama Hitoshi,Ohki Rieko

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep19174.pdf

Reference42 articles.

1. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell 88, 323–331 (1997).

2. Aylon, Y. & Oren, M. Living with p53, dying of p53. Cell 130, 597–600 (2007).

3. Harris, S. L. & Levine, A. J. The p53 pathway: positive and negative feedback loops. Oncogene 24, 2899–2908 (2005).

4. Vousden, K. H. & Prives, C. Blinded by the Light: The Growing Complexity of p53. Cell 137, 413–431 (2009).

5. Vousden, K. H. & Ryan, K. M. p53 and metabolism. Nat Rev Cancer 9, 691–700 (2009).

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The PP2A regulator IER5L supports prostate cancer progression;Cell Death & Disease;2024-07-18

2. Predictive value of immediate early response 5 like (IER5L) in the prognosis and immune checkpoint blockade therapy of non-small cell lung cancer patients;Pathology - Research and Practice;2024-04

3. Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition;2024-02-26

4. Potential roles for mitochondria-to-HSF1 signaling in health and disease;Frontiers in Molecular Biosciences;2023-12-18

5. Repression motif in HSF1 regulated by phosphorylation;Cellular Signalling;2023-10